Applied Finance Capital Management, LLC Regeneron Pharmaceuticals, Inc. Transaction History
Applied Finance Capital Management, LLC
- $2.34 Trillion
- Q3 2024
A detailed history of Applied Finance Capital Management, LLC transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Applied Finance Capital Management, LLC holds 279,823 shares of REGN stock, worth $213 Million. This represents 1.07% of its overall portfolio holdings.
Number of Shares
279,823
Previous 30,153
828.01%
Holding current value
$213 Million
Previous $31.7 Billion
21.23%
% of portfolio
1.07%
Previous 1.47%
Shares
9 transactions
Others Institutions Holding REGN
# of Institutions
1,533Shares Held
83.8MCall Options Held
1.22MPut Options Held
1.51M-
Vanguard Group Inc Valley Forge, PA9.32MShares$7.11 Billion0.18% of portfolio
-
Black Rock Inc. New York, NY8.45MShares$6.44 Billion0.2% of portfolio
-
Jpmorgan Chase & CO New York, NY7.49MShares$5.71 Billion0.65% of portfolio
-
State Street Corp Boston, MA4.9MShares$3.74 Billion0.21% of portfolio
-
Capital World Investors Los Angeles, CA4.3MShares$3.28 Billion0.72% of portfolio
About REGENERON PHARMACEUTICALS, INC.
- Ticker REGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 107,190,000
- Market Cap $81.7B
- Description
- Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...